CSIG-22. MUTATIONAL HETEROGENEITY OF THE EGFR EXTRACELLULAR DOMAIN PROMOTES AN ONCOGENIC UNTETHERED TRANSITIONAL CONFORMATION AND THE POTENTIAL FOR GREATER THERAPEUTIC TARGETING IN GBM PATIENTS

JSON

Thorne AH, Orellana L, Parisian A, Cavenee W, Furnari F

Neuro-oncology 18 (suppl_6) vi45-vi45 [2016-11-01; online 2016-11-07]

DOI 10.1093/neuonc/now212.183

Crossref 10.1093/neuonc/now212.183